Careers
Trial Participants
Investors
Submit an RFP
Choose Language
Search
Scientific Expertise
Scientific Expertise >
Therapeutic Areas
Therapeutic Areas >
Autoimmune Disease
Cardiovascular
Dermatology
Diabetes and Endocrinology
Hematology
Hepatology
Infectious Diseases and Vaccines
Nephrology
Neuroscience
Obesity
Oncology
Ophthalmology
Respiratory and Pulmonary
Women's Health
Specialty Areas
Specialty Areas >
Cell and Gene Therapies
Pediatrics
Rare Diseases
Global Solutions
Global Solutions >
Clinical Development
Clinical Development >
Early: Phase I / IIa
Late: Phase IIb / III
RWE and Post-Approval Studies
Decentralized Clinical Trials
Clinical Data Management, Analysis and Reporting
Clinical Trial Project Management and Monitoring
Patient Safety & Pharmacovigilance
Diversity and Inclusion in Clinical Trials
Clinical Pharmacology
Clinical Pharmacology >
Clinical Research Units (CRUs)
Fortrea Consulting Services
Fortrea Consulting Services >
Regulatory Strategy Consulting
Market Access & HEOR Strategy
Product Development Consulting
Enabling Technologies
Enabling Technologies >
Mobile Clinical Services
Full, Functional & Hybrid Service Models
Full, Functional & Hybrid Service Models >
Patient Access
Patient Access >
Specialty Pharmacy
Medical Device and Diagnostic Development
Medical Device and Diagnostic Development >
Medical Device Development
In Vitro Diagnostic (IVD) Development
Fortrea Site Connections
Fortrea Site Connections >
Site Technology
Site Advisory Board
Our Customers
Our Customers >
Pharmaceutical
Pharmaceutical >
Biotechnology
Biotechnology >
MedTech
MedTech >
About Us
About Us >
Blog
Blog >
Locations
Locations >
Investors
Investors >
Leadership
Leadership >
Newsroom
Newsroom >
Events & Webinars
Events & Webinars >
Quality
Quality >
The Fortrea Culture
The Fortrea Culture >
Careers
Choose Language
Contact Us
Back
Search